Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE3
100 participants
INTERVENTIONAL
2025-05-01
2025-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does oral methadone improve post-operative pain scores as compared to standard treatment? Does oral methadone lead to reduced use of post-operative and post-discharge opioid usage as compared to the current standard treatment?
Researchers will compare oral methadone to a placebo (a look-alike substance that contains no drug) to assess the questions above.
Participants will:
Receive either oral methadone or a look-alike placebo before surgery Receive standard intraoperative and immediate post-operative pain control at the anesthesiologist's discretion Be asked about their pain levels in the recovery area Keep a diary of pain and opioid usage over the first 2 days after surgery
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidural Methadone in Healthy Volunteers
NCT03525509
Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain
NCT00356083
Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
NCT00315835
Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
NCT03266445
Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.
NCT01793480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be recruited and consented to whether they want to participate in the study by a member of the team during a pre-operative clinic visit (Anesthesia START clinic or orthopedic surgery clinic) or on day-of-surgery in the pre-op holding area.
Participants will be randomized to either the control group or treatment group using randomization software. Participants assigned to the intervention group will receive a single dose of oral methadone will be administered in the pre-operative holding area. Dosing will be weight dependent, using 0.15mg/kg ideal body weight (IBW) as a reference; participants weighing less than 50kg will receive 5mg oral methadone, while participants weighing more than 50kg will receive 10mg oral methadone. Participants assigned to the control group will receive an identical-looking placebo sugar pill. A study pharmacist will deliver the appropriate pill to the patient or pre-op nurse in the pre-op holding area on the day of surgery.
Pre-operatively, all participants will complete a survey collecting data on visual analog scale (VAS) pain scores for the 2 weeks leading up to surgery, whether this is different from their baseline pain score at home (if applicable), and pre-operative opioid usage (if applicable). All participants will receive standard-of-care pre-operative non-opioid medications as determined by the orthopedic surgical team if needed.
Intraoperatively, participants will receive either GA or monitored anesthesia care, at the discretion of the anesthesia care team.
In the post-anesthesia acute care unit (PACU), all participants will receive standard PACU medications (ie. intravenous dilaudid or oral oxycodone, and acetaminophen as needed) for pain relief. Pain scores on a 1-10 scale and amount of opioid usage will be collected per standard PACU protocol upon arrival, after 30 minutes, and after 60 minutes. Post-discharge, all participants will receive oxycodone-acetaminophen for at-home pain (as standardized by the orthopedic surgery team) to be used as needed for breakthrough pain refractory to acetaminophen/ibuprofen, or in patients where these medications are contraindicated.
Following discharge, a member of the study team will call participants on post-operative day 1 and post-operative day 2 to assess pain scores and opioid usage. Participants will also be discharged with a pain diary to assist in documenting endpoints. They will also be asked to document any complications or adverse events at each of these time intervals.
Once the data collection is complete, we will perform statistics (detailed below) to determine if there is any significant difference. The primary outcome will be post-discharge opioid usage, and the secondary outcome will be patient-perceived pain scores at the time intervals above.
STRATIFICATION/DESCRIPTIVE FACTORS/RANDOMIZATION SCHEME
Participants will not be stratified prior to randomization.
Descriptive factors: age, gender, BMI will be looked to assess for possible confounding variables, but will not affect group assignment.
The website randomizer.org will assist in our randomization of participants enrolled in the study. The software randomly determines which participant will be assigned to Control vs Treatment group in a 1:1 ratio. At the onset of the study, we will create a predetermined randomization list (containing study participant code and treatment arm assignment), and provide it to the study pharmacist who will then be the only one with access to this linked info. The study pharmacist will be informed of the new enrollment and will read back the study code to the team member, who will record it in a separate data collection form that contains link between Medical Record Number and participant code. The pharmacist will strike out the participant code on their sheet to keep track of used codes, then prepare the appropriate medication and deliver it to the participant or pre-op nurse in the pre-op holding area on the day of surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
placebo sugar pill and standard intraoperative pain control using short-acting opioids, with drug choice and dosing at the practitioner's discretion
Placebo
sugar pill that is identical look-alike to study drug
Interventional
5mg PO methadone for participants \<50kg or 10mg PO methadone for participants \>50kg
Methadone group
5mg PO methadone for participants \<50kg or 10mg PO methadone for participants \>50kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methadone group
5mg PO methadone for participants \<50kg or 10mg PO methadone for participants \>50kg
Placebo
sugar pill that is identical look-alike to study drug
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keck School of Medicine of USC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abigail Song
Co-Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Chen, M.D.
Role: PRINCIPAL_INVESTIGATOR
Keck School of Medicine of USC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USC Healthcare Consultation 3
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Vender JS, Benson J, Newmark RL. Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Posterior Spinal Fusion Surgery: A Randomized, Double-blinded, Controlled Trial. Anesthesiology. 2017 May;126(5):822-833. doi: 10.1097/ALN.0000000000001609.
Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Shear T, Parikh KN, Patel SS, Gupta DK. Intraoperative Methadone for the Prevention of Postoperative Pain: A Randomized, Double-blinded Clinical Trial in Cardiac Surgical Patients. Anesthesiology. 2015 May;122(5):1112-22. doi: 10.1097/ALN.0000000000000633.
Murphy GS, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Dickerson D, Bilimoria S, Benson J, Maher CE, Trenk GJ, Teister KJ, Szokol JW. Postoperative Pain and Analgesic Requirements in the First Year after Intraoperative Methadone for Complex Spine and Cardiac Surgery. Anesthesiology. 2020 Feb;132(2):330-342. doi: 10.1097/ALN.0000000000003025.
Murphy GS, Avram MJ, Greenberg SB, Benson J, Bilimoria S, Maher CE, Teister K, Szokol JW. Perioperative Methadone and Ketamine for Postoperative Pain Control in Spinal Surgical Patients: A Randomized, Double-blind, Placebo-controlled Trial. Anesthesiology. 2021 May 1;134(5):697-708. doi: 10.1097/ALN.0000000000003743.
Komen H, Brunt LM, Deych E, Blood J, Kharasch ED. Intraoperative Methadone in Same-Day Ambulatory Surgery: A Randomized, Double-Blinded, Dose-Finding Pilot Study. Anesth Analg. 2019 Apr;128(4):802-810. doi: 10.1213/ANE.0000000000003464.
Kharasch ED, Brunt LM, Blood J, Komen H. Intraoperative Methadone in Next-day Discharge Outpatient Surgery: A Randomized, Double-blinded, Dose-finding Pilot Study. Anesthesiology. 2023 Oct 1;139(4):405-419. doi: 10.1097/ALN.0000000000004663.
Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24.
undefined
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APP-24-00554
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.